{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Copanlisib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Copanlisib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Copanlisib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "copanlisib",
    "trial_2_text": "Copanlisib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Copanlisib Supplement: 60 participants will take Copanlisib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Copanlisib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Copanlisib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.34277427196502686,
      "78": 0.2710696756839752,
      "17": 0.21042491495609283,
      "123": 0.21030193567276,
      "189": 0.20981371402740479,
      "20": 0.2000434249639511,
      "188": 0.18094398081302643,
      "173": 0.1701834797859192,
      "177": 0.16701005399227142,
      "228": 0.16356126964092255,
      "64": 0.16020764410495758,
      "68": 0.15943306684494019,
      "37": 0.15921077132225037,
      "21": 0.15918906033039093,
      "9": 0.1535024344921112,
      "67": 0.14581115543842316,
      "49": 0.13988754153251648,
      "77": 0.12644034624099731,
      "101": 0.12610849738121033,
      "46": 0.12314079701900482,
      "14": 0.11491984128952026,
      "2": 0.11464676260948181,
      "200": 0.1120690181851387,
      "79": 0.10642969608306885,
      "350": 0.10185130685567856,
      "29": 0.09729597717523575,
      "193": 0.09702420234680176,
      "114": 0.09653560072183609,
      "243": 0.09640185534954071,
      "239": 0.09423436224460602,
      "126": 0.08880981802940369,
      "85": 0.08730780333280563,
      "72": 0.085372194647789,
      "261": 0.08192979544401169,
      "179": 0.08161323517560959,
      "104": 0.0798160657286644,
      "38": 0.07863248884677887,
      "194": 0.07855057716369629,
      "131": 0.07723430544137955,
      "76": 0.07108114659786224,
      "27": 0.07054929435253143,
      "86": 0.07034499943256378,
      "191": 0.06913801282644272,
      "355": 0.06871113181114197,
      "180": 0.06758574396371841,
      "122": 0.06702978909015656,
      "5": 0.06640391051769257,
      "139": 0.06547139585018158,
      "102": 0.06334807723760605,
      "396": 0.06213373690843582,
      "61": 0.0613759383559227,
      "116": 0.06120825558900833,
      "28": 0.06032953038811684,
      "234": 0.06013888865709305,
      "35": 0.05976983904838562,
      "36": 0.059594638645648956,
      "30": 0.05765453353524208,
      "288": 0.05718725919723511,
      "151": 0.05681820586323738,
      "130": 0.05629710480570793,
      "249": 0.05610146000981331,
      "341": 0.055492743849754333,
      "147": 0.055019889026880264,
      "82": 0.054681211709976196,
      "186": 0.05467657744884491,
      "441": 0.052562814205884933,
      "33": 0.05175427719950676,
      "144": 0.05166465416550636,
      "136": 0.051511362195014954,
      "204": 0.05150415748357773,
      "212": 0.05095505714416504,
      "269": 0.05048295110464096,
      "18": 0.04998999461531639,
      "154": 0.04899165779352188,
      "1": 0.04824472591280937,
      "69": 0.047928523272275925,
      "282": 0.04738180711865425,
      "96": 0.04678922891616821,
      "356": 0.046742502599954605,
      "92": 0.045434363186359406,
      "466": 0.044461674988269806,
      "253": 0.043841198086738586,
      "211": 0.04366610571742058,
      "276": 0.043476056307554245,
      "100": 0.043229587376117706,
      "142": 0.04222370311617851,
      "221": 0.041547056287527084,
      "75": 0.0408409908413887,
      "164": 0.04065728560090065,
      "97": 0.040569230914115906,
      "422": 0.04021769016981125,
      "132": 0.040175799280405045,
      "454": 0.04001419246196747,
      "361": 0.03981317579746246,
      "297": 0.03973390907049179,
      "339": 0.03945925459265709,
      "286": 0.0394134446978569,
      "4": 0.03923214226961136,
      "256": 0.03851904720067978,
      "489": 0.03748440369963646
    },
    "trial_2_ae": {
      "87": 0.34277427196502686,
      "78": 0.2710696756839752,
      "17": 0.21042491495609283,
      "123": 0.21030193567276,
      "189": 0.20981371402740479,
      "20": 0.2000434249639511,
      "188": 0.18094398081302643,
      "173": 0.1701834797859192,
      "177": 0.16701005399227142,
      "228": 0.16356126964092255,
      "64": 0.16020764410495758,
      "68": 0.15943306684494019,
      "37": 0.15921077132225037,
      "21": 0.15918906033039093,
      "9": 0.1535024344921112,
      "67": 0.14581115543842316,
      "49": 0.13988754153251648,
      "77": 0.12644034624099731,
      "101": 0.12610849738121033,
      "46": 0.12314079701900482,
      "14": 0.11491984128952026,
      "2": 0.11464676260948181,
      "200": 0.1120690181851387,
      "79": 0.10642969608306885,
      "350": 0.10185130685567856,
      "29": 0.09729597717523575,
      "193": 0.09702420234680176,
      "114": 0.09653560072183609,
      "243": 0.09640185534954071,
      "239": 0.09423436224460602,
      "126": 0.08880981802940369,
      "85": 0.08730780333280563,
      "72": 0.085372194647789,
      "261": 0.08192979544401169,
      "179": 0.08161323517560959,
      "104": 0.0798160657286644,
      "38": 0.07863248884677887,
      "194": 0.07855057716369629,
      "131": 0.07723430544137955,
      "76": 0.07108114659786224,
      "27": 0.07054929435253143,
      "86": 0.07034499943256378,
      "191": 0.06913801282644272,
      "355": 0.06871113181114197,
      "180": 0.06758574396371841,
      "122": 0.06702978909015656,
      "5": 0.06640391051769257,
      "139": 0.06547139585018158,
      "102": 0.06334807723760605,
      "396": 0.06213373690843582,
      "61": 0.0613759383559227,
      "116": 0.06120825558900833,
      "28": 0.06032953038811684,
      "234": 0.06013888865709305,
      "35": 0.05976983904838562,
      "36": 0.059594638645648956,
      "30": 0.05765453353524208,
      "288": 0.05718725919723511,
      "151": 0.05681820586323738,
      "130": 0.05629710480570793,
      "249": 0.05610146000981331,
      "341": 0.055492743849754333,
      "147": 0.055019889026880264,
      "82": 0.054681211709976196,
      "186": 0.05467657744884491,
      "441": 0.052562814205884933,
      "33": 0.05175427719950676,
      "144": 0.05166465416550636,
      "136": 0.051511362195014954,
      "204": 0.05150415748357773,
      "212": 0.05095505714416504,
      "269": 0.05048295110464096,
      "18": 0.04998999461531639,
      "154": 0.04899165779352188,
      "1": 0.04824472591280937,
      "69": 0.047928523272275925,
      "282": 0.04738180711865425,
      "96": 0.04678922891616821,
      "356": 0.046742502599954605,
      "92": 0.045434363186359406,
      "466": 0.044461674988269806,
      "253": 0.043841198086738586,
      "211": 0.04366610571742058,
      "276": 0.043476056307554245,
      "100": 0.043229587376117706,
      "142": 0.04222370311617851,
      "221": 0.041547056287527084,
      "75": 0.0408409908413887,
      "164": 0.04065728560090065,
      "97": 0.040569230914115906,
      "422": 0.04021769016981125,
      "132": 0.040175799280405045,
      "454": 0.04001419246196747,
      "361": 0.03981317579746246,
      "297": 0.03973390907049179,
      "339": 0.03945925459265709,
      "286": 0.0394134446978569,
      "4": 0.03923214226961136,
      "256": 0.03851904720067978,
      "489": 0.03748440369963646
    }
  },
  "safety": {
    "trial_1_safety": 0.40384721755981445,
    "trial_2_safety": 0.40384721755981445
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.48406457901000977
  }
}